Big Step for Development of Cedal pharmaceutical products

You are here:

Following the official registration of Cedal in Iraq and successful negotiations with both private and public sectors, the company has finalized its product sales agreement in the Iraqi market.

Cedal, which achieved formal registration in Iraq in 2023, successfully secured this agreement after extensive discussions with several private sector companies to transfer its representation. This achievement marks a significant milestone in introducing high-quality Iranian pharmaceutical products to the Iraqi market.

With the superior quality of Cedal’s products and their compliance with international standards, it is anticipated that a joint production agreement in Iraq will also be finalized by mid-2025. This collaboration has the potential to create new opportunities for technology transfer and employment in the pharmaceutical industries of both countries.

This agreement represents a critical step in strengthening the international presence of Cedal and establishing sustainable connections in the regional pharmaceutical market. It is not only a turning point for expanding Iran’s pharmaceutical exports but also a foundation for fostering broader economic and commercial collaborations between Iran and Iraq.

جست‌وجو
مطالب مرتبط